# Oral Administration of STC-15 in Subjects With Advanced Malignancies

> **NCT05584111** · PHASE1 · COMPLETED · sponsor: **STORM Therapeutics LTD** · enrollment: 42 (actual)

## Conditions studied

- Advanced Cancer
- Advanced Solid Tumor
- Cancer

## Interventions

- **DRUG:** STC-15

## Key facts

- **NCT ID:** NCT05584111
- **Lead sponsor:** STORM Therapeutics LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-15
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-12-22
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2025-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05584111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05584111, "Oral Administration of STC-15 in Subjects With Advanced Malignancies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05584111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*